|
84
|
378
|
4amtA |
Crystal structure at 2.6a of human prorenin |
|
68
|
330
|
4apeA |
The active site of aspartic proteinases |
|
84
|
313
|
4aa9A |
Camel chymosin at 1.6a resolution |
|
98
|
386
|
4acxA |
Aminoimidazoles as bace-1 inhibitors. x-ray crystal structure of beta secretase complexed with compound 23 |
|
88
|
325
|
4aprE |
Structures of complexes of rhizopuspepsin with pepstatin and other statine-containing inhibitors |
|
98
|
390
|
3zovA |
Crystal structure of bace-1 in complex with chemical ligand |
|
92
|
384
|
3zkiA |
Bace2 mutant structure with ligand |
|
86
|
330
|
3wz7A |
Endothiapepsin in complex with gewald reaction-derived inhibitor (6) |
|
87
|
382
|
3zkxA |
Ternary bace2 xaperone complex |
|
91
|
385
|
3zksA |
Bace2 xaperone complex with inhibitor |
|
86
|
330
|
3wz8A |
Endothiapepsin in complex with gewald reaction-derived inhibitor (8) |
|
88
|
330
|
3wz6A |
Endothiapepsin in complex with gewald reaction-derived inhibitor (5) |
|
93
|
384
|
3zknA |
Bace2 fab inhibitor complex |
|
74
|
382
|
3zl7A |
Bace2 fynomer complex |
|
91
|
387
|
3wb4A |
Crystal structure of beta secetase in complex with 2-amino-3,6-dimethyl-6-(2-phenylethyl)-3,4,5,6-tetrahydropyrimidin-4-one |
|
92
|
384
|
3zkmA |
Bace2 fab complex |
|
98
|
386
|
3zkqA |
Bace2 xaperone complex |
|
92
|
384
|
3zkgA |
Bace2 mutant apo structure |
|
92
|
387
|
3wb5A |
Crystal structure of beta secetase in complex with (6s)-2-amino-3,6-dimethyl-6-[(1r,2r)-2-phenylcyclopropyl]-3,4,5,6-tetrahydropyrimidin-4-one |
|
101
|
391
|
3zmgA |
Crystal structure of bace-1 in complex with chemical ligand |
|
95
|
382
|
3zlqA |
Bace2 xaperone complex |
|
90
|
340
|
3vyeA |
Human renin in complex with inhibitor 7 |
|
88
|
340
|
3vydA |
Human renin in complex with inhibitor 6 |
|
85
|
340
|
3vyfA |
Human renin in complex with inhibitor 9 |
|
89
|
387
|
3vv8A |
Crystal structure of beta secetase in complex with 2-amino-3-methyl-6-((1s,2r)-2-(3'-methylbiphenyl-4-yl)cyclopropyl)pyrimidin-4(3h)-one |
|
90
|
340
|
3vucA |
Human renin in complex with compound 5 |
|
91
|
389
|
3vv7A |
Crystal structure of beta secetase in complex with 2-amino-6-((1s,2r)-2-(3'-methoxybiphenyl-3-yl)cyclopropyl)-3-methylpyrimidin-4(3h)-one |
|
88
|
340
|
3vswA |
Human renin in complex with compound 8 |
|
86
|
389
|
3vv6A |
Crystal structure of beta secetase in complex with 2-amino-3-methyl-6-((1s, 2r)-2-phenylcyclopropyl)pyrimidin-4(3h)-one |
|
80
|
340
|
3vsxA |
Human renin in complex with compound 18 |
|
77
|
335
|
3vcmA |
Crystal structure of human prorenin |
|
99
|
388
|
3vg1A |
Crystal structure of human beta secretase in complex with nvp-bur436, derived from a soaking experiment |
|
102
|
389
|
3veuA |
Crystal structure of human beta secretase in complex with nvp-avi326 |
|
101
|
388
|
3vf3A |
Crystal structure of human beta secretase in complex with nvp-bqq711 |
|
100
|
400
|
3udmA |
Crystal structure of bace with compound 8 |
|
102
|
400
|
3udhA |
Crystal structure of bace with compound 1 |
|
82
|
329
|
3uriA |
Endothiapepsin-db5 complex. |
|
96
|
389
|
3uflA |
Discovery of pyrrolidine-based b-secretase inhibitors: lead advancement through conformational design for maintenance of ligand binding efficiency |
|
90
|
329
|
3urjA |
Type iv native endothiapepsin |
|
100
|
400
|
3udkA |
Crystal structure of bace with compound 6 |
|
93
|
391
|
3uqwA |
Crystal structure of bace1 with its inhibitor |
|
102
|
400
|
3udyA |
Crystal structure of bace with compound 11 |
|
102
|
400
|
3udpA |
Crystal structure of bace with compound 12 |
|
100
|
400
|
3udqA |
Crystal structure of bace with compound 13 |
|
82
|
326
|
3utlA |
Human pepsin 3b |
|
102
|
400
|
3udrA |
Crystal structure of bace with compound 14 |
|
100
|
400
|
3udnA |
Crystal structure of bace with compound 9 |
|
84
|
329
|
3urlA |
Endothiapepsin-db6 complex. |
|
100
|
400
|
3udjA |
Crystal structure of bace with compound 5 |
|
96
|
391
|
3tpjA |
Apo structure of bace1 |
